Company Overview

Deltagen Research Laboratories, L.L.C., a computational drug discovery company, is engaged in applying proprietary design technology and rapid synthesis capabilities to accelerate the discovery process for new drugs and chemical products. In addition, the company is using its approach on internal programs to discover new lead candidates. In October 1999, Deltagen Research entered into an agreement and plan of merger with DuPont Pharma, Inc., an indirect wholly owned subsidiary of E.I. du Pont de Nemours and Company and DPC Newco, Inc., a wholly owned subsidiary of DuPont Pharma. Pursuant to the terms of the merger agreement, DPC would be merged with and into the company, which would become a...

Deltagen Research Laboratories, L.L.C., a computational drug discovery company, is engaged in applying proprietary design technology and rapid synthesis capabilities to accelerate the discovery process for new drugs and chemical products. In addition, the company is using its approach on internal programs to discover new lead candidates. In October 1999, Deltagen Research entered into an agreement and plan of merger with DuPont Pharma, Inc., an indirect wholly owned subsidiary of E.I. du Pont de Nemours and Company and DPC Newco, Inc., a wholly owned subsidiary of DuPont Pharma. Pursuant to the terms of the merger agreement, DPC would be merged with and into the company, which would become a wholly owned subsidiary of DuPont Pharma. The company was formerly known as Bristol-Myers Squibb Pharma Research Labs L.L.C. and changed its name to Deltagen Research Laboratories, L.L.C. in February 2002. The company was founded in 1994 and is based in San Diego, California. As of February 19, 2002, Deltagen Research Laboratories, L.L.C. operates as a subsidiary of Deltagen Inc.

Key Executives for Deltagen Research Laboratories, L.L.C.

Similar Private Companies By Industry

Recent Private Companies Transactions